Evidence map›Paper›PMID 26563166›Full record

ArticleMycopathologia2016

The First Case of Invasive Mixed-Mold Infections Due to Emericella nidulans var. echinulata and Rasamsonia piperina in a Patient with Chronic Granulomatous Disease.

Naruhiko Ishiwada, Kenichi Takeshita, Takashi Yaguchi, Koo Nagasawa, Noriko Takeuchi, Haruka Hishiki, Akira Watanabe, Katsuhiko Kamei, Naoki Shimojo

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Mycopathologia, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Taxonomy and evolution ofComputational and structural biotechnology journal · 2018
    Review
  5. SystemicJMM case reports · 2017
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Naruhiko IshiwadaDepartment of Infectious Diseases, Medical Mycology Research Center, Chiba University, Chiba, Japan. ishiwada@faculty.chiba-u.jp.
Kenichi TakeshitaDepartment of Pediatrics, Graduate School of Medicine, Chiba University, Chiba, Japan.
Takashi YaguchiDivision of Bioresources, Medical Mycology Research Center, Chiba University, Chiba, Japan.
Koo NagasawaDepartment of Pediatrics, Graduate School of Medicine, Chiba University, Chiba, Japan.
Noriko TakeuchiDepartment of Infectious Diseases, Medical Mycology Research Center, Chiba University, Chiba, Japan.
Haruka HishikiDepartment of Pediatrics, Graduate School of Medicine, Chiba University, Chiba, Japan.
Akira WatanabeDepartment of Infectious Diseases, Medical Mycology Research Center, Chiba University, Chiba, Japan.
Katsuhiko KameiDepartment of Infectious Diseases, Medical Mycology Research Center, Chiba University, Chiba, Japan.
Naoki ShimojoDepartment of Pediatrics, Graduate School of Medicine, Chiba University, Chiba, Japan.
Chiba University · JPChiba University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 16-year-old boy with chronic granulomatous disease presented with pneumonia and rib osteomyelitis. Emericella nidulans var. echinulata was isolated from his sputum. After starting voriconazole, Rasamsonia piperina was isolated from the rib swelling. A combination therapy of voriconazole and micafungin effectively eradicated this invasive mixed-mold infection. In immunocompromised patients, a precise pathogenic diagnosis is clinically useful for administration of an appropriate treatment regimen.

Indexed as

AdolescentAntifungal AgentsAscomycotaCoinfectionEchinocandinsEmericellaGranulomatous Disease, ChronicHumansImmunocompromised HostLipopeptidesMaleMicafunginMycosesSputumVoriconazoleAntifungal AgentsEchinocandinsLipopeptidesMicafunginVoriconazoleChronic granulomatous diseaseEmericella nidulans var. echinulataMicafunginRasamsonia piperinaVoriconazole

Identifiers

PMID26563166
OpenAlexW2278756150

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.